#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Liposarcoma recurrent Cardiac failure acute Ischaemic stroke Blood iron increased Synovitis Osteogenesis imperfecta Epidermolysis bullosa Cutaneous T-cell lymphoma recurrent Glioblastoma multiforme Gestational trophoblastic tumour Infection in an immunocompromised host Sickle cell disease Heavy menstrual bleeding Hepatoblastoma More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Basic Information Inclusion body myositis – Treatment Primary mediastinal large B-cell lymphoma – Trials in Disease Langerhans cell sarcoma – Trials in Disease Langerhans cell sarcoma – Treatment Progressive multifocal leukoencephalopathy – Trials in Disease Von Willebrand’s disease – Treatment Mantle cell lymphoma stage III – Diagnostics Ewing’s sarcoma recurrent – Diagnostics Hereditary angioedema More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valoctocogene Roxaparvovec Formoterol Fumarate Dihydrate Evx-01 Levoleucovorin Disodium Bosutinib N-Acetylhistidine Eo2318 Imidapril Hydrochloride Pc14586 Olive Oil, Refined Plasma Sertraline Hydrochloride Florbetapir (18F) Ale.c04 Carbidopa Altizide Fostemsavir Trometamol Retifanlimab Daunorubicin Ligelizumab More therapies…

    Learn about Your Condition

    Vestibular disorder Alcoholism Colitis Obsessive-compulsive disorder Hereditary optic atrophy Hairy cell leukaemia recurrent Aortic disorder Foot deformity Corticobasal degeneration Melanoma recurrent Endometrial cancer metastatic Macular telangiectasia Impaired gastric emptying Coronary artery disease Hepatorenal syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of Ghrelin’s Effects on Decision-Making and Gambling Behavior in Healthy Adults: Comparison with Placebo

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Lenomorelin
    • Sodium Chloride
    Sweden

  • Study on Insulin Aspart for Recovery from Low Blood Sugar in People with and without Type 2 Diabetes

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Aspart
    Austria

  • Study on the Effects of RO7204239 and Tirzepatide for Weight Loss in Patients with Obesity or Overweight with a Weight-Related Health Issue

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Human Latent Myostatin
    • Tirzepatide
    Poland Spain

  • Study on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Maridebart Cafraglutide
    Bulgaria Czechia Germany Hungary Italy Poland

  • Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Maridebart Cafraglutide
    Belgium Czechia Denmark Finland Germany Italy +2

  • Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Canagliflozin
    • Dulaglutide
    • Linagliptin
    Spain
Previous Page
1 … 36 37 38 39 40 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!